Keywords: further, pollinex, quattro, data, allergy, therapeutics, uk-based

Further Pollinex Quattro data from Allergy Therapeutics

Article | 16 June 2008

Print This

UK-based company Allergy Therapeutics has announced further results from the G301 Phase III trial of Pollinex Quattro Grass annual injection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in